Fedora Pharmaceuticals' Unattributed Round

Fedora Pharmaceuticals raised a round of funding on May 10, 2013.

Fedora Pharmaceuticals is dedicated to the discovery and development of antibiotics targeting life-threatening microbial drug resistance. The company's pipeline includes the β-Lactamase inhibitors wi…

Articles about Fedora Pharmaceuticals' Unattributed Round: